5.38 - 5.60
4.95 - 8.28
2.3K / 2.4K (Avg.)
-279.00 | -0.02
Steady, sustainable growth is a hallmark of high-quality businesses. Value investors watch these metrics to confirm that the company's fundamental performance aligns with—or outpaces—its current market valuation.
-0.66%
Both firms have declining sales. Martin Whitman would suspect an industry slump or new disruptive entrants.
-0.66%
Both firms have negative gross profit growth. Martin Whitman would question the sector’s viability or cyclical slump.
194.23%
Positive EBIT growth while UPM.HE is negative. John Neff might see a substantial edge in operational management.
194.23%
Positive operating income growth while UPM.HE is negative. John Neff might view this as a competitive edge in operations.
127.94%
Positive net income growth while UPM.HE is negative. John Neff might see a big relative performance advantage.
128.57%
Positive EPS growth while UPM.HE is negative. John Neff might see a significant comparative advantage in per-share earnings dynamics.
128.57%
Positive diluted EPS growth while UPM.HE is negative. John Neff might view this as a strong relative advantage in controlling dilution.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
-204.88%
Both companies show negative OCF growth. Martin Whitman would analyze broader economic or industry conditions limiting cash flow.
-292.31%
Both companies show negative FCF growth. Martin Whitman would consider an industry-wide capital spending surge or margin compression.
1.13%
Positive 10Y revenue/share CAGR while UPM.HE is negative. John Neff might see a distinct advantage in product or market expansion over the competitor.
1.13%
Positive 5Y CAGR while UPM.HE is negative. John Neff might see an underappreciated edge for the firm vs. the competitor.
1.13%
Positive 3Y CAGR while UPM.HE is negative. John Neff might view this as a sharp short-term edge or successful pivot strategy.
-542.92%
Negative 10Y OCF/share CAGR while UPM.HE stands at 0.00%. Joel Greenblatt would scrutinize managerial effectiveness and product competitiveness.
-542.92%
Negative 5Y OCF/share CAGR while UPM.HE is at 113.45%. Joel Greenblatt would question the firm’s operational model or cost structure.
-542.92%
Negative 3Y OCF/share CAGR while UPM.HE stands at 12.39%. Joel Greenblatt would demand an urgent turnaround in the firm’s cost or revenue drivers.
117.29%
Positive 10Y CAGR while UPM.HE is negative. John Neff might see a substantial advantage in bottom-line trajectory.
117.29%
Positive 5Y CAGR while UPM.HE is negative. John Neff might view this as a strong mid-term relative advantage.
117.29%
Positive short-term CAGR while UPM.HE is negative. John Neff would see a clear advantage in near-term profit trajectory.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
6.77%
Inventory growth well above UPM.HE's 8.27%. Michael Burry suspects overshooting production or weaker sell-through vs. the competitor.
-6.29%
Negative asset growth while UPM.HE invests at 1.63%. Joel Greenblatt checks if the competitor might capture more market share unless our returns remain higher.
3.46%
Positive BV/share change while UPM.HE is negative. John Neff sees a clear edge over a competitor losing equity.
-17.87%
We’re deleveraging while UPM.HE stands at 8.08%. Joel Greenblatt considers if we gain a balance-sheet advantage for potential downturns.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.